amlexanox has been researched along with Lysosomal Enzyme Disorders in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banning, A | 1 |
| Schiff, M | 1 |
| Tikkanen, R | 1 |
1 other study available for amlexanox and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria.
Topics: Amino Acid Substitution; Aminopyridines; Aspartylglucosaminuria; Aspartylglucosylaminase; Cells, Cul | 2018 |